GPT Healthcare Valuation
Is 544131 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 544131 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 544131 (₹170.65) is trading above our estimate of fair value (₹52.21)
Significantly Below Fair Value: 544131 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 544131?
Key metric: As 544131 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 544131's PE Ratio? | |
|---|---|
| PE Ratio | 28.6x |
| Earnings | ₹490.72m |
| Market Cap | ₹14.03b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.5x |
| Enterprise Value/EBITDA | 17.4x |
| PEG Ratio | 1.4x |
Price to Earnings Ratio vs Peers
How does 544131's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 46.7x | ||
524520 KMC Speciality Hospitals (India) | 48.4x | n/a | ₹12.6b |
SHALBY Shalby | 43.5x | 59.6% | ₹23.8b |
INDRAMEDCO Indraprastha Medical | 26.8x | n/a | ₹39.5b |
ARTEMISMED Artemis Medicare Services | 68.2x | 35.1% | ₹44.1b |
544131 GPT Healthcare | 28.6x | 21.0% | ₹14.0b |
Price-To-Earnings vs Peers: 544131 is good value based on its Price-To-Earnings Ratio (28.6x) compared to the peer average (46.7x).
Price to Earnings Ratio vs Industry
How does 544131's PE Ratio compare vs other companies in the IN Healthcare Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
523696 Fortis Malar Hospitals | 2.1x | n/a | US$11.96m |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 544131 is good value based on its Price-To-Earnings Ratio (28.6x) compared to the Indian Healthcare industry average (43.1x).
Price to Earnings Ratio vs Fair Ratio
What is 544131's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 28.6x |
| Fair PE Ratio | 47x |
Price-To-Earnings vs Fair Ratio: 544131 is good value based on its Price-To-Earnings Ratio (28.6x) compared to the estimated Fair Price-To-Earnings Ratio (47x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Mohini Health & Hygiene
₹893.6m
Engages in the manufacture and sale of health and hygiene products in India.
MHHL
₹49.20
7D
-0.6%
1Y
-28.0%
Dr Lalchandani Labs
₹78.0m
Provides diagnostic and related healthcare tests and services in India.
541299
₹18.00
7D
-3.9%
1Y
n/a
N G Industries
₹561.0m
Provides various healthcare services in India.
530897
₹168.70
7D
-0.3%
1Y
0.8%